UPMC Hillman Cancer Center - Monroeville — Monroeville, Pennsylvania

UPMC Hillman Cancer Center - Monroeville is a clinical research site located in Monroeville, Pennsylvania, United States 15146.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center - Monroeville has participated in 63 clinical trials with 58 currently active.

Therapeutic areas: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center - Monroeville?

UPMC Hillman Cancer Center - Monroeville has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center - Monroeville conducted?

UPMC Hillman Cancer Center - Monroeville has 63 clinical trials on record, with 58 currently active. Their work covers Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Is UPMC Hillman Cancer Center - Monroeville accredited by Crixeo Health?

Yes — UPMC Hillman Cancer Center - Monroeville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UPMC Hillman Cancer Center - Monroeville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.